Christopher Robert Palma MD ScM (He/Him)

Rheumatology•Canandaigua, NY

Lupus & Related, Rheumatoid Arthritis & Related, Vasculitis

Assistant Professor of Medicine

Join to View Full Profile

335 Parrish StCanandaigua, NY 14424
Phone+1 585-486-0901
Fax+1 585-340-5399

Education & Training

University of Rochester Medical CenterFellowship, Rheumatology, 2014 - 2016
University of Rochester Medical CenterResidency, Internal Medicine, 2011 - 2014
University of Rochester School of Medicine and DentistryClass of 2011
Johns Hopkins Bloomberg School of Public HealthScM, Microbiology and Immunology, 2005 - 2007
Johns Hopkins UniversityScM, 2005 - 2007
Yale UniversityBS, Biology, 2001 - 2005
Yale UniversityB.S., 2001 - 2005

Certifications & Licensure

NY State Medical License 2013 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

Fellow American College of Rheumatology, 2016
Fellow American Board of Internal Medicine, 2014
Fellow American College of Medicine, 2014
George H whippe Award University of Rochester School of Medicine, 2010
Tettleman Travel Scholarship Yale University, 2004
Join now to see all

Clinical Trials

Safety and Efficacy Study of IFX-1 in add-on to Standard of Care in GPA and MPA Start of enrollment: 2018 Oct 15
Terminated
Phase 2
COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders Start of enrollment: 2021 Aug 13
Completed
Phase 2
Immune Modulators for Treating COVID-19 Start of enrollment: 2020 Oct 15
Completed
Phase 3
Assessment of Efficacy and Safety of Ruxolitinib in Participants With COVID-19-Associated ARDS Who Require Mechanical Ventilation (RUXCOVID-DEVENT) Start of enrollment: 2020 May 24
Terminated
Phase 3
Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19 Start of enrollment: 2020 Jun 10
Completed
Phase 1, Phase 2
A Study to Evaluate the Safety and Efficacy of Upadacitinib in Participants With Giant Cell Arteritis Start of enrollment: 2019 Feb 06
COMPLETED
PHASE3
A Study to Evaluate the Change in Disease State and Adverse Events in Adult Participants With Polymyalgia Rheumatica (PMR) Dependent on Glucocorticoid Treatment, Receiving Subcutaneous Injections of ABBV-154 Start of enrollment: 2021 Sep 09
TERMINATED
PHASE2
Join now to see all

Publications & Presentations

PubMed

SARS-CoV-2 N protein and anti-spike serologies: insights into COVID-19 disease severity and mortality-a secondary analysis of the ACTIV-1 trial.
Alfredo J Mena Lora, Kimi Enders, Huimin Wu, Luis Parra-Rodriguez, Christopher Palma
Therapeutic Advances in Infectious Disease. 2025-04-22
38 citations
Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial.
Jane A O'Halloran, Emily R Ko, Kevin J Anstrom, Eyal Kedar, Matthew W McCarthy
JAMA. 2023-07-25
19 citations
Randomized Phase 3 Trial of Ruxolitinib for COVID-19-Associated Acute Respiratory Distress Syndrome.
Lindsay Rein, Karel Calero, Ronak Shah, Charles Ojielo, Kristin M Hudock
Critical Care Medicine. 2022-12-01

Journal Articles

Characterization of di-, tri-, and tetranucleotide microsatellite markers with perfect repeats for Trypanosoma brucei and related species
Balmer O; Palma C; Macleod A; Caccone A, Molecular Ecology Notes, 1/1/2006

Abstracts/Posters

Anakinra is effecitve and well tolerated in medically complex patients including transplant recipients with gout.
Christopher Palma, Taylor Topping, Darren Tabechain, American College of Rheumatology Annual Meeting, 1/1/2016

Lectures

Breathlessness in scleroderma
Rochester, NY - 1/1/2018

Professional Memberships

American College of Rheumatology - ACR
Member
American College of Physicians - ACP
Fellow

External Links

profilehttps://www.urmc.rochester.edu/medicine/allergy/faculty/christopher-palma.aspx